OrganiGram Holdings Inc.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December 31, 2023, on Tuesday, February 13, 2024, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, February 13, 2024 Time: 8:00 am Easte.

Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis today announced that it has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, a health and sciences organization dedicated to the medical applications of cannabinoids. Organigram is pleased to complete its first shipment to Germany, one of the world's largest and growing medical markets,.

Organigram Completes First Shipment to Germany, Extending its International Reach

Aurora Cannabis

Canopy Growth

Cronos Group

GrowGeneration Corp

SNDL Inc.

Tilray Brands

Given recent news items regarding the federal legalization of cannabis, you may think now is the time to be thinking about which cannabis stocks to buy, not which cannabis stocks to sell. Yes, the release of a letter from the U.S. Department of Health and Human Services, recommending that marijuana be rescheduled as a Schedule III drug, may be seen as signs of marijuana legalization progress.

7 Cannabis Stocks to Sell as the Industry Faces Legal Uncertainty in 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has closed the first of three tranches of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the first tranche closing, the Investor acquired 12,893,175 com.

Organigram Announces the First Tranche Closing from BAT Investment

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company's annual general and special meeting held on January 18, 2024. “We are thrilled to welcome Karina to our Board of Directors. Her extensive expertise in marketing and brand management combined with her ongoing experience with BAT will be a tremendous asset to our Board,” said Peter Amirault, Bo.

Organigram Announces Appointment of Karina Gehring to Board of Directors

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on January 18, 2024 (the “Meeting”). Election of Directors Each of the nine nominees listed in the Company's management information circular dated December 20, 2023 (the “Circular”) provided in connection with the Meeting were elected as directors of the Comp.

Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT

Organigram's Q4 results exceeded revenue expectations but had weaker than expected adjusted EBITDA. Analysts have lowered their projections for Organigram's revenue and adjusted EBITDA for FY24 and FY25. British American Tobacco (BAT) is buying a larger stake in Organigram at a significant premium, but not acquiring the entire company.

Why Organigram Is My Favorite Cannabis Stock

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “Circular”) and related materials (the “Meeting Materials”) for its annual and special meeting (the “Meeting”) of the holders of its common shares (the “Shareholders”) to be held on January 18, 2024. In addition to routine annual business to be conducted (includin.

Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting

Organigram Holdings Inc. (OGI) Q4 2023 Earnings Call Transcript

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter and thirteen months ended September 30, 2023 (“Q4 Fiscal 2023” or "Fiscal 2023"). "In Fiscal 2023, our continued focus on innovative products that address consumers' evolving preferences toward convenience drove our growth across several ready-to-consume categories like pre-rolls and edibles, and we en.

Organigram Reports Fiscal 2023 Results1

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to the role of Chief Financial Officer effective January 8, 2024. Mr. Guyatt will lead Organigram's Finance and IT divisions and will report directly to Beena Goldenberg, Organigram's Chief Executive Officer. Mr. Guyatt is a seasoned financial executive with over 25 years of in.

Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer

Innovative Industrial Properties

In the bustling stock markets, the cannabis industry has emerged as a dynamic arena, captivating investors with its promise of rapid evolution and immense growth potential. As the smoke clears from regulatory shifts and market fluctuations, the spotlight shines on three trailblazing cannabis stocks poised for substantial strides in 2024.

Budding Potential: 3 Cannabis Stocks Poised for Growth in 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2023 ended September 30, 2023, on Tuesday, December 19, 2023, before market open. The Company will host a conference call to discuss its results with details as follows: Date: Tuesday, December 19, 2023 Time: 8:00 am E.

Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Leafly Holdings

Valley National

As 2024 looms on the horizon, the cannabis sector stands at the cusp of an exciting era. This likely surge is fueled by a blend of political backing and a shift in public opinion.

Rescheduling & Legalization: 7 Cannabis Stocks Set to Surge in 2024

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is thrilled to announce it has won KIND Magazine's (“KIND”) Innovation of the Year award for its revolutionary SHRED X Rip-Strips Hash. This is the second time Organigram has won this coveted award, having previously won for the Company's patented Edison JOLTS ingestible extract product. “We are very proud to be recognized by.

Organigram Wins KIND Magazine's Innovation of the Year for SHRED X Rip-Strips Hash

Are marijuana stock investors using volatility to their advantage? As most know the cannabis sector is a place where most of the pot stocks trade with inconsistent patterns. Now to elaborate most companies trade with patterns that often show major volatility. This is what makes it tough to identify when it is time to buy or sell. To be more descriptive when there is a jump in trading you do not know how long it will last.

3 Canadian Marijuana Stocks To Watch Today

Philip Morris

Cannabis stocks are gaining more and more reputation in the market. Many companies are developing amazing products for either medicinal or recreational use.

The 3 Best Cannabis Stocks to Buy in December

In an August 2023 column, I wrote “With the chances of marijuana companies accessing the U.S. financial system higher than ever and cannabis stocks trading at lower valuations than ever before, now looks like an excellent time to seek out top-notch cannabis stocks to buy.” I also identified three cannabis companies with very attractive valuations and strong outlooks.

3 Underperforming Cannabis Stocks You Better Not Be Buying

TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that Phylos Bioscience Inc. (“Phylos”), a U.S. cannabis genetics company and provider of production ready seeds, has achieved the first milestone under the loan agreement entered into in May 2023 (the “Loan Agreement”) and has closed the second tranche under the Loan Agreement with Organigram advancing US$2.75 million to Phylos. T.

Organigram Increases Investment in Phylos After Successful Milestone Achievement

As Thanksgiving week approaches, attention turns to top Canadian marijuana stocks. The global cannabis industry is experiencing remarkable growth. Canada, a leader in cannabis production and legalization, is advancing in tandem. This growth presents exciting opportunities for investors. In addition, key Canadian cannabis companies are expected to show significant market activity. This period is critical for those monitoring the cannabis sector.

Thanksgiving Watchlist: Leading Canadian Cannabis Stocks

Toronto, Ontario--(Newsfile Corp. - November 22, 2023) - General Assembly Holdings Limited (TSXV: GA) (the "Company" or "GA Pizza"), a Toronto based pizza business, is pleased to announce that it has entered into a letter of intent ("LOI") dated November 20, 2023, with CanPR Technology Inc. ("CanPR"), an Ontario-based technology company focused on providing technology-based solutions relating to web applications, mobile development, e-commerce, and data and analytics for the immigration sector, pursuant to which the Company proposes to acquire all of the issued and outstanding shares of CanPR (the "CanPR Shares") by way of a reverse takeover transaction (the "Proposed RTO"), such that, upon closing, the current shareholders of CanPR (the "Target Shareholders") will own 90.9% of the issued and outstanding shares of the Company (the "GA Shares") on a non-diluted basis. The resulting entity from the Proposed RTO (the "Resulting Issuer") will continue the business of CanPR as a company listed on the TSX Venture Exchange ("TSXV").

General Assembly Enters into Letter of Intent with CanPR Technology Inc. for Reverse Takeover and Change of Business Transaction

Roundhill Cannabis ETF

Despite some market pessimism surrounding next year and the often prophesied recession, there are still oversold marijuana stocks to buy that offer great value. The companies on this list benefit from the emerging health benefits of these plants and the continued liberalization of what were once illicit drugs in the U.S. I foresee a rise in these oversold marijuana stocks due to industry tailwinds and falling bond prices, which will ease some pressure on risk assets in the marijuana industry.

3 Oversold Marijuana Stocks to Buy Now

Organigram Holdings Inc. OGI, -9.38% OGI, -8.52% said Friday it is launching a search for a new finance chief due to the departure of Derrick West in the job. West told the company he needs to take time to focus on his health and recovery following surgery this month, Organigram said.

Canadian cannabis company OrganiGram searching for new CFO

TORONTO--(BUSINESS WIRE)--The Board of Directors (the “Board”) of Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) today announced that Derrick West has informed Organigram that he will transition away from his role as Chief Financial Officer (“CFO”) in order to take time to focus on his health and recovery following surgery later this month. Paolo De Luca, current Chief Strategy Officer, has been appointed interim CFO effective November 13, 2023, while the Comp.

Organigram Announces Interim Chief Financial Officer

Bumble

BioNTech SE

Freshpet

Tesla

Dish Network (NASDAQ:DISH), down 10% to $4.94, reported a drop in third-quarter revenue amid declining pay-TV subscribers,  triggering a loss for its fiscal third quarter. The US owner of the direct-broadcast satellite provider Dish said in a statement that pay-TV subscribers decreased by roughly 64,000 in Q3, compared to a net increase of approximately 30,000 in the year-ago quarter.

News for OrganiGram Holdings Inc. Stock (OGI)